Target intelligence / Profile preview

Potassium channel ATP-sensitive subunit Kir6.2 (Kir6.2)

Target
Kir6.2
Molecular classification
Ion channel (specifically: inward rectifier potassium channel), Pore-forming subunit of ATP-sensitive potassium channel
01

Overview

The ATP-sensitive potassium channel is an **octameric complex** comprising four **Kir6.2 subunits** and four regulatory **sulfonylurea receptor subunits (SUR1)**. Kir6.2 forms the channel pore and is the site for direct ATP-mediated inhibition. The channel is a central metabolic sensor: high intracellular ATP (energy-rich state) closes the channel by binding to Kir6.2, while low ATP (energy-depleted state) allows it to open, permitting **K\(_\{\}\)\(^{+}\) efflux** and regulating membrane potential. In pancreatic beta cells, this mechanism controls insulin secretion by coupling glucose metabolism to electrical activity. The channel is clinically significant as the target of antidiabetic sulfonylureas and other drugs, and is implicated in multiple metabolic and neurological diseases due to genetic variation or abnormal regulation.

Other names
Inward rectifier potassium channel Kir6.2KCNJ11K\(_\{\text{ATP}\}\) channel subunit Kir6.2ATP-sensitive potassium channel pore subunit Kir6.2
02

Mechanism of action

Sulfonylureas and meglitinides bind to the regulatory SUR1 subunit, leading to closure of the Kir6.2 pore and stimulation of insulin secretion ATP binds directly to Kir6.2, causing channel closure and reducing K\(_\{\}\)\(^{+}\) efflux, which depolarizes the cell membrane and promotes insulin release ADP and Mg-nucleotides can modulate channel activity via SUR1 Channel openers like diazoxide stabilize the open state

03

Biological functions

Glucose sensing and insulin secretion in pancreatic beta cellsRegulation of vascular smooth muscle toneLinking cellular metabolic state to membrane electrical activityNeuroprotection/seizure protection
04

Disease associations

Type 2 diabetes mellitus and neonatal diabetes (mutations reduce ATP sensitivity, impairing insulin secretion)Congenital hyperinsulinism (loss-of-function mutations)Epilepsy and muscle weakness (some Kir6.2 mutations)Cardiovascular disease (role in vascular smooth muscle and cardiac myocytes)
05

Safety considerations

Risk of hypoglycemia (from over-inhibition of K\(_\{\text{ATP}\}\))Drug-induced hyperglycemia or treatment failure in diabetes (if channel mutations reduce drug sensitivity)Potential cardiac arrhythmias with non-selective K\(_\{\text{ATP}\}\) modulationNeurological symptoms (seizure, developmental delay) in some genetic syndromes
06

Interacting drugs

Sulfonylureas: glibenclamide, glyburide, glipizide, tolbutamide

3 more in the full profile.

07

Biomarkers

Kir6.2 and SUR1 gene mutations (KCNJ11, ABCC8) for neonatal diabetes and congenital hyperinsulinismGlucose responsiveness in pancreatic beta cells (indirect clinical biomarker)

Beyond the preview

Go deeper on Potassium channel ATP-sensitive subunit Kir6.2 (Kir6.2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel ATP-sensitive subunit Kir6.2 (Kir6.2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call